Loading organizations...
Loading organizations...
Microbiome engineering company developing novel microbial therapies.
Finch Therapeutics has raised $189.0M across 4 funding rounds.
Finch Therapeutics has raised $189.0M in total across 4 funding rounds.
Finch Therapeutics has raised $189.0M in total across 4 funding rounds.
Finch Therapeutics's investors include Avenir, Baupost Group, Humboldt Fund, MSD Capital, MSD Partners, Octave Group, OCV Partners, Nick Haft, Shumway Capital, SIG, SymBiosis, Trans-Pacific Technology Fund.
Finch Therapeutics has raised $189.0M across 4 funding rounds. Most recently, it raised $90.0M Series D in September 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 17, 2020 | $90.0M Series D | Avenir, Baupost Group, Humboldt Fund, MSD Capital, MSD Partners, Octave Group, OCV Partners, Nick Haft, Shumway Capital, SIG, SymBiosis, Trans-Pacific Technology Fund, Willett Advisors | |
| Aug 22, 2019 | $53.0M Series C | Avenir, Morgan Noble Healthcare Partners, OCV Partners, Shumway Capital, Susquehanna International Group, SymBiosis, Trans-Pacific Technology Fund, Willett Advisors | |
| Mar 1, 2018 | $36.0M Series B | Avenir, Morgan Noble Healthcare Partners, Chris Shumway, Willett Advisors | |
| Apr 6, 2017 | $10.0M Other Equity | Takeda |